CMC & Regulatory Affairs

TDP’s Product Due Diligence – CMC & Regulatory Affairs service provides a detailed, structured assessment of an asset’s development maturity, regulatory positioning, and lifecycle strategy value proposition and value add options. The focus is on evaluating the robustness of CMC data, regulatory pathway credibility, and alignment with global regulatory expectations, ensuring that technical and regulatory claims withstand independent scrutiny.

Our approach goes beyond document review. We assess the internal logic, regulatory defensibility, and scalability of the development strategy, identifying hidden risks that may impact approval timelines, commercial viability, or transaction value. Areas of high risk of regulatory push back and evaluations.

The output is a clear, decision-focused analysis of development readiness, approval probability, technical robustness, and lifecycle sustainability, supporting informed investment, acquisition, licensing, or partnership decisions.

A stylized blood drop with a medical cross in a circle, featuring a gradient of red, purple, and blue colors.

Due Diligence

BEST FOR

Investment, acquisition, licensing or partnership decisions

Stylized blood drop with a medical cross inside a circle, in a gradient of purple and red.

Assets where approval probability, timelines, or claims need validating

Icon of a blood drop with a medical plus sign inside a circle, outlined in gradient purple and red colors.

Teams needing clarity on CMC robustness and regulatory defensibility

Blood drop with a medical cross inside a circle, symbolizing medical or health services related to blood donation or transfusion.

WHAT WE ASSESS

Robustness and credibility of CMC data and development maturity

An illustration of a blood drop with a medical plus symbol inside, using gradient colors from red to purple.

Regulatory pathway credibility and alignment to global expectations

Medical symbol with a drop and a cross inside a circle, in gradient purple and red colors.

Internal logic and defensibility of the development strategy

Stylized blood drop with a medical cross inside a circle, gradient color from red to purple.

Scalability and lifecycle sustainability risks

Stylized line art of a blood drop with a medical cross inside a circle, gradient from red to purple.

Areas likely to trigger regulatory pushback or delay

Stylized blood drop with a medical cross inside a circle, gradient from red to purple.

Hidden technical/regulatory risks that impact value

Stylized blood drop with a cross inside a circle, gradient outline from red to purple.

OUTPUTS

Decision-focused analysis of readiness and approval probability

A stylized blood droplet with a medical cross inside a circle, featuring a gradient color scheme from red to purple.

Key risks, assumptions, and value-impacting gaps

Medical dropper icon with a plus sign inside a circle.

Clear implications for timeline, feasibility and transaction value

Illustration of a blood drop with a medical cross inside a circle, using gradient colors from purple to red.
Request a call back →
Request a call back →